Table 1 Treatment of metastatic sarcoma by treatment line
Any treatment line | 1st treatment line | 2nd treatment line | 3rd treatment line | 4th or higher treatment line | |
|---|---|---|---|---|---|
N = 145 | N = 145 | N = 83 | N = 49 | N = 52a | |
Metastatic Surgery (MS) | 33 (22.8%) | 25 (19.1%) | 11 (14.5%) | 1 (2.2%) | 2 (3.9%) |
Missing data | 14 | 7 | 4 | 1 | |
Radiotherapy (RT) | 44 (30.3%) | 20 (14.5%) | 16 (20.5%) | 6 (13.0%) | 11 (22.0%) |
Missing data | 7 | 5 | 3 | 2 | |
Systemic treatment (ST) | 107 (73.8%) | 95 (68.8%) | 62 (78.5%) | 35 (72.9%) | 42 (82.4%) |
Missing data | 7 | 4 | 1 | 1 | |
Treatment combinations | N = 145 | N = 111 | N = 74 | N = 41 | - |
MS + RT | 2 (1.4%) | 1 (0.9%) | 1 (1.4%) | 0 (0.0%) | - |
MS + ST | 14 (9.7%) | 11 (9.9%) | 4 (5.4%) | 0 (0.0%) | - |
RT + ST | 20 (13.8%) | 9 (8.1%) | 8 (10.2%) | 1 (2.4%) | - |
MS + RT + ST | 5 (3.4%) | 4 (3.6%) | 1 (1.4%) | 0 (0.0%) | - |